IGF-1 (insulin growth factor-1)/Akt (protein kinase B) signals can attenuate these AGE-related detrimental effects and can therefore represent an interesting therapeutic target to counteract AGE-induced sarcopenia [13,40]. This evidence concerns the gene AKT1 and sarcopenia.